Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#31 / 83 Total
SEEL - Seelos Therapeutics Inc - Stock Price Chart
TickerSEEL [NASD]
CompanySeelos Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap4.12MEPS (ttm)-42.75
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y62.30%
P/S2.09EPS next 5Y-
P/B-EPS Q/Q94.28%
Dividend-Sales Q/Q-28.34%
Insider Own-Inst Own104.81%
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom1.00Target Price32.00
Avg Volume63.36K52W Range1.92 - 398.40
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of products that address significant unmet needs in Central Nervous System (CNS) disorders and other rare disorders. The company was founded by Raj Mehra in 1987 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mehra RajSee RemarksDec 01 '23Buy1.3275,75799,999185,142Dec 01 04:16 PM
Golembiewski Michael JosephChief Financial OfficerNov 30 '23Buy1.2183,000100,22286,450Dec 01 04:16 PM
XXII - 22nd Century Group Inc - Stock Price Chart
TickerXXII [NASD]
Company22nd Century Group Inc
CountryUSA
IndustryTobacco
Market Cap10.98MEPS (ttm)-102.71
P/E-EPS this Y82.97%
Forward P/E-EPS next Y23.39%
PEG-EPS past 5Y-49.91%
P/S0.20EPS next 5Y-
P/B-EPS Q/Q85.43%
Dividend-Sales Q/Q-70.54%
Insider Own0.00%Inst Own6.43%
Insider Trans-Inst Trans-
Short Float1.14%EarningsMay 15/b
Analyst Recom2.00Target Price53.28
Avg Volume1.53M52W Range1.45 - 170.40
22nd Century Group, Inc. is a biotechnology company, which engages in the business of tobacco harm reduction, reduced nicotine tobacco, and improvement of health and wellness through plant science. It operates through the Tobacco and Hemp/Cannabis segments. The Tobacco segment manufactures branded filtered cigars and cigarettes. The Hemp/Cannabis segment focuses on the bulk ingredient distillate or isolate. The company was founded on September 12, 2005 and is headquartered in Buffalo, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Arno AndrewDirectorJan 05 '24Buy0.17100,00017,490100,000Jan 08 08:04 PM
FIRESTONE LAWRENCEChief Executive OfficerJan 04 '24Buy0.17100,00017,360100,000Jan 05 04:32 PM
ZPTA - Zapata Computing Holdings Inc. - Stock Price Chart
TickerZPTA [NASD]
CompanyZapata Computing Holdings Inc.
CountryUSA
IndustrySoftware - Infrastructure
Market Cap29.10MEPS (ttm)-4.21
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S23.85EPS next 5Y-
P/B-EPS Q/Q-44077.42%
Dividend-Sales Q/Q-
Insider Own37.49%Inst Own5.53%
Insider Trans0.00%Inst Trans6.72%
Short Float2.44%Earnings-
Analyst Recom-Target Price-
Avg Volume1.17M52W Range0.90 - 18.50
Zapata Computing Holdings, Inc. operates as a generative AI company. It provides data science and engineering techniques for solutions on an industrial scale. The company was founded by Christopher Savoie, Alan Aspuru-Guzik, Yudong Cao, Jonathan Olson, Peter Johnson, and Jonathan Romero-Fontalvo in 2017 and is headquartered in Boston, MA.
BPTH - Bio-Path Holdings Inc - Stock Price Chart
TickerBPTH [NASD]
CompanyBio-Path Holdings Inc
CountryUSA
IndustryBiotechnology
Market Cap3.36MEPS (ttm)-27.34
P/E-EPS this Y71.22%
Forward P/E-EPS next Y17.36%
PEG-EPS past 5Y34.89%
P/S-EPS next 5Y-
P/B-EPS Q/Q63.17%
Dividend-Sales Q/Q-
Insider Own0.11%Inst Own23.89%
Insider Trans0.00%Inst Trans99.87%
Short Float2.84%EarningsMay 15/b
Analyst Recom1.00Target Price20.00
Avg Volume1.47M52W Range2.08 - 44.80
Bio-Path Holdings, Inc. is a biotechnology company, which engages in the development of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline includes Prexigebersen, BP1001-A, BP1002, and BP1003. The company was founded by Peter H. Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007 and is headquartered in Bellaire, TX.
CNTG - Centogene NV - Stock Price Chart
TickerCNTG [NASD]
CompanyCentogene NV
CountryGermany
IndustryDiagnostics & Research
Market Cap10.31MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-32.60%
P/S-EPS next 5Y-
P/B-EPS Q/Q-13.12%
Dividend-Sales Q/Q-80.94%
Insider Own57.02%Inst Own8.96%
Insider Trans0.00%Inst Trans-0.69%
Short Float0.33%Earnings-
Analyst Recom1.00Target Price1.50
Avg Volume146.82K52W Range0.36 - 1.98
Centogene NV is a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. It operates through the following segments: Pharmaceutical, Diagnostics, and Corporate. The Pharmaceutical segment provides solutions to pharmaceutical partners, including target discovery, early patient recruitment and identification, epidemiological insights, and biomarker discovery. The Diagnostics segment offers genetic sequencing and diagnostics services to clients, who are typically physicians, laboratories, or hospitals, either directly or through distributors. The Other segment covers COVID-19 testing services to clients. The company was founded by Arndt Rolf and Christoph Ehlers in 2006 and is headquartered in Rostock, Denmark.
HLTH - Cue Health Inc - Stock Price Chart
TickerHLTH [NASD]
CompanyCue Health Inc
CountryUSA
IndustryHealth Information Services
Market Cap15.34MEPS (ttm)-2.44
P/E-EPS this Y37.33%
Forward P/E-EPS next Y40.73%
PEG-EPS past 5Y-103.84%
P/S0.22EPS next 5Y-
P/B0.06EPS Q/Q-355.70%
Dividend-Sales Q/Q-87.19%
Insider Own29.58%Inst Own37.62%
Insider Trans0.00%Inst Trans3.20%
Short Float0.56%EarningsMay 13/b
Analyst Recom3.00Target Price0.75
Avg Volume795.27K52W Range0.09 - 0.89
Cue Health, Inc. is a healthcare technology company that puts consumers in control of their health information and places diagnostic information at the center of care. It enables people to manage their health through real-time, actionable, and connected health information, offering individuals and their healthcare providers easy access to lab-quality diagnostics anywhere, anytime, in a device that fits in the palm of the hand. The firms first-of-its-kind COVID-19 test was the first FDA-authorized molecular diagnostic test for at-home and over-the-counter use without a prescription and physician supervision. The company was founded by Ayub Khattak and Clint Sever in 2010 and is headquartered in San Diego, CA.
EDBL - Edible Garden AG Inc - Stock Price Chart
TickerEDBL [NASD]
CompanyEdible Garden AG Inc
CountryUSA
IndustryFarm Products
Market Cap1.91MEPS (ttm)-47.17
P/E-EPS this Y63.72%
Forward P/E-EPS next Y70.43%
PEG-EPS past 5Y32.73%
P/S0.13EPS next 5Y-
P/B-EPS Q/Q69.11%
Dividend-Sales Q/Q27.58%
Insider Own12.25%Inst Own1.36%
Insider Trans-30.20%Inst Trans-
Short Float22.72%EarningsMay 15/b
Analyst Recom1.00Target Price12.00
Avg Volume907.10K52W Range3.61 - 89.60
Edible Garden AG, Inc. is a controlled environment agriculture (CEA) farming company, which engages in the usage of traditional agricultural growing techniques together with technology to grow organic food. Its products include lettuces, potted herbs, and cut herbs. The company was founded by James E. Kras and Michael C. James on March 28, 2020 and is headquartered in Belvidere, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
UBS Group AG10% OwnerApr 25 '24Buy6.071,0056,10535,077May 03 12:04 PM
UBS Group AG10% OwnerApr 25 '24Sale5.4330,056163,3075,025May 03 12:04 PM
UBS Group AG10% OwnerApr 24 '24Sale6.3010666834,076May 03 12:04 PM
DonAroma PamelaDirectorJun 02 '23Buy1.511,0001,5101,000Jun 06 04:30 PM
TCS - Container Store Group Inc - Stock Price Chart
TickerTCS [NYSE]
CompanyContainer Store Group Inc
CountryUSA
IndustrySpecialty Retail
Market Cap40.77MEPS (ttm)-2.09
P/E-EPS this Y12.50%
Forward P/E-EPS next Y-28.57%
PEG-EPS past 5Y-
P/S0.05EPS next 5Y15.30%
P/B0.25EPS Q/Q67.85%
Dividend-Sales Q/Q-20.67%
Insider Own34.35%Inst Own32.42%
Insider Trans0.00%Inst Trans-1.65%
Short Float1.22%EarningsMay 14/b
Analyst Recom4.00Target Price2.00
Avg Volume248.29K52W Range0.81 - 3.71
The Container Store Group, Inc. is a holding company, which engages in the retail of storage and organization products and solutions. It operates through The Container Store and Elfa segments. The Container Store segment focuses on retail stores, website and call centers, as well as the installation and organizational services business. The Elfa segment includes the design and manufacture of component-based shelving and drawer systems and made-to-measure sliding doors. The company was founded in 1978 and is headquartered in Coppell, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Malhotra SatishCEO & PRESIDENTNov 13 '23Buy1.8216,71530,359754,653Nov 15 07:26 PM
Malhotra SatishCEO & PRESIDENTAug 31 '23Buy2.4412,41730,307737,938Sep 01 05:49 PM
Jordan Robert EDirectorAug 30 '23Buy2.3530,00070,506224,059Sep 01 04:59 PM
Saha DhritimanCHIEF OPERATING OFFICERAug 08 '23Buy2.545,00012,700175,665Aug 09 08:23 PM
MILLER JEFFREY ACHIEF FINANCIAL OFFICERAug 04 '23Buy2.603,86010,023210,234Aug 04 05:16 PM
EXAS - Exact Sciences Corp. - Stock Price Chart
TickerEXAS [NASD]
CompanyExact Sciences Corp.
CountryUSA
IndustryDiagnostics & Research
Market Cap9.30BEPS (ttm)-1.32
P/E-EPS this Y0.33%
Forward P/E-EPS next Y98.88%
PEG-EPS past 5Y4.59%
P/S3.67EPS next 5Y-
P/B2.96EPS Q/Q-45.59%
Dividend-Sales Q/Q5.82%
Insider Own1.04%Inst Own89.56%
Insider Trans-5.35%Inst Trans-1.72%
Short Float4.86%EarningsMay 08/a
Analyst Recom1.33Target Price86.61
Avg Volume2.78M52W Range51.91 - 100.77
EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Conroy Kevin TPresident and CEOMay 01 '24Sale60.151,15569,4731,156,191May 02 07:00 PM
Cunningham EverettChief Commercial OfficerMay 01 '24Sale60.151368,18047,042May 02 07:00 PM
Elliott Jeffrey ThomasChief Financial OfficerMay 01 '24Sale60.151368,18011,795May 02 07:00 PM
Baranick BrianEVP, GM., Precision OncologyMay 01 '24Sale60.151106,61613,279May 02 07:00 PM
Condella SarahEVP, Human ResourcesMay 01 '24Sale60.151026,13572,611May 02 07:00 PM
HSDT - Helius Medical Technologies Inc - Stock Price Chart
TickerHSDT [NASD]
CompanyHelius Medical Technologies Inc
CountryUSA
IndustryMedical Devices
Market Cap3.74MEPS (ttm)-12.96
P/E-EPS this Y62.43%
Forward P/E-EPS next Y44.97%
PEG-EPS past 5Y63.34%
P/S5.59EPS next 5Y-
P/B0.66EPS Q/Q30.36%
Dividend-Sales Q/Q21.62%
Insider Own4.61%Inst Own3.02%
Insider Trans8.37%Inst Trans-
Short Float2.66%EarningsMay 13/a
Analyst Recom1.00Target Price4.00
Avg Volume541.45K52W Range1.49 - 14.44
Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain's ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded in 2014 and is headquartered in Newtown, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ANDREEFF DANEPresident and CEODec 14 '23Buy8.105,00040,47516,512Dec 15 07:00 AM
ANDREEFF DANEPresident and CEODec 01 '23Buy6.452,00612,93513,685Dec 04 08:30 AM
ANDREEFF DANEPresident and CEONov 30 '23Buy6.372,00012,74112,551Dec 04 08:30 AM
ANDREEFF DANEPresident and CEOAug 30 '23Buy7.645,00038,21211,420Aug 30 08:42 PM
ANDREEFF DANEPresident and CEOAug 28 '23Buy6.375,07832,3398,774Aug 30 08:42 PM
123456789